AMPH vs CCI · P/E 12, rev $732.0M vs P/E 40, rev $6.57B
Amphastar P (AMPH) versus Crown Castle (CCI) — a side-by-side from cached financials, not a winner call.
Amphastar P (AMPH) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Crown Castle (CCI) is a reit - specialty company listed on US.
Latest reported AMPH revenue for 2024-12-31 was $732.0M. Net income was $159.5M. Revenue was up 13.6% from 2023-12-31 to 2024-12-31. AMPH currently screens at market cap $880.1M and trailing P/E 12.0.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
AMPH currently screens at market cap $880.1M and trailing P/E 12.0. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
Not investment advice. Open the AMPH and CCI stock pages for the full models.
Not investment advice.